| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
|
|
|
||||||||
|
||||||||||
Clinical Investigations |
1 Second Department of Internal Medicine, Gunma University School of Medicine, Maebashi, Japan
2 Department of Diagnostic Radiology and Nuclear Medicine, Gunma University School of Medicine, Maebashi, Japan
3 Department of Laboratory Sciences, Gunma University School of Health Science, Maebashi, Japan
4 Fujioka General Hospital, Fujioka, Japan
Cardiac PET using 18F-FDG under fasting conditions (fasting 18F-FDG PET) is a promising technique for identification of cardiac sarcoidosis and assessment of disease activity. The aim of this study was to investigate the usefulness of fasting 18F-FDG PET in detecting inflammatory lesions of cardiac sarcoidosis from a pathophysiologic standpoint. Methods: Twenty-two patients with systemic sarcoidosis were classified into 2 groups of 11 each according to the presence or absence of sarcoid heart disease. Cardiac sarcoidosis was diagnosed according to the Japanese Ministry of Health and Welfare guidelines for diagnosing cardiac sarcoidosis with the exception of scintigraphic criteria. Nuclear cardiac imaging with fasting 18F-FDG PET, 99mTc-methoxyisobutylisonitrile (99mTc-MIBI) SPECT, and 67Ga scintigraphy were performed in all patients. PET and SPECT images were divided into 13 myocardial segments and the standardized uptake value (SUV) of 18F-FDG was calculated and defect scores (DS) for 99mTc-MIBI uptake were assessed for each segment. The total SUV (T-SUV) and total DS (TDS) were calculated as the sum of measurements for all 13 segments, and the diagnostic accuracy of fasting 18F-FDG PET was compared with that of the other nuclear imaging modalities. In addition, pathophysiologic relationships between inflammatory activity and myocardial damage were examined by segmental comparative study using the SUV and DS. Results: In patients with cardiac sarcoidosis, fasting 18F-FDG PET revealed a higher frequency of abnormal myocardial segments than 99mTc-MIBI SPECT (mean number of abnormal segments per patient: 6.6 ± 3.0 vs. 3.0 ± 3.2 [mean ± SD], P < 0.05). The sensitivity of fasting 18F-FDG PET in detecting cardiac sarcoidosis was 100%, significantly higher than that of 99mTc-MIBI SPECT (63.6%) or 67Ga scintigraphy (36.3%). The accuracy of fasting 18F-FDG PET was significantly higher than 67Ga scintigraphy. The T-SUV demonstrated a good linear correlation with serum angiotensin-converting enzyme levels (r = 0.83, P < 0.01), and the TDS showed a significant negative correlation with the left ventricular ejection fraction (r = –0.82, P < 0.01). In abnormal myocardial segments on the nuclear scan, the SUV showed a significant negative correlation with the DS (r = –0.63, P < 0.0001). Conclusion: This study suggests that fasting 18F-FDG PET can detect the early stage of cardiac sarcoidosis, in which fewer perfusion abnormalities and high inflammatory activity are noted, before advanced myocardial impairment.
Key Words: PET • 18F-FDG • fasting • cardiac sarcoidosis
Related articles in JNM:
This article has been cited by other articles:
|
|
 |
|
  A. M. McDIVIT and A. T. ASKARI A middle-aged man with progressive fatigue Cleveland Clinic Journal of Medicine, October 1, 2009; 76(10): 564 - 574. [Full Text] [PDF]
|
|
|
|
 |
|
 F. Mehrhof, M. Stockburger, H. Schuette, W. Haverkamp, and R. Dietz Ventricular tachycardia as the first manifestation of cardiac sarcoidosis BMJ Case Reports, April 28, 2009; 2009(apr23_1): bcr0820080810 - bcr0820080810. [Abstract] [Full Text]
|
|
|
|
|
|
S Gyorik, L Ceriani, A Menafoglio, A Gallino, and R Wyttenbach 18F-FDG PET scan as follow-up tool for sarcoidosis with symptomatic cardiac conduction disturbances requiring a pacemaker BMJ Case Reports, February 18, 2009; 2009(feb16_1): bcr2006070805 - bcr2006070805. [Full Text]
|
|
|
|
 |
|
 S Gyorik, L Ceriani, A Menafoglio, A Gallino, and R Wyttenbach 18F-FDG PET scan as follow-up tool for sarcoidosis with symptomatic cardiac conduction disturbances requiring a pacemaker Thorax, June 1, 2007; 62(6): 560 - 560. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Pandya, R. C. Brunken, P. Tchou, P. Schoenhagen, and D. A. Culver Detecting cardiac involvement in sarcoidosis: a call for prospective studies of newer imaging techniques Eur. Respir. J., February 1, 2007; 29(2): 418 - 422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Nishiyama, Y. Yamamoto, K. Fukunaga, H. Takinami, Y. Iwado, K. Satoh, and M. Ohkawa Comparative Evaluation of 18F-FDG PET and 67Ga Scintigraphy in Patients with Sarcoidosis J. Nucl. Med., October 1, 2006; 47(10): 1571 - 1576. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R Doughan and B. R Williams Cardiac sarcoidosis Heart, February 1, 2006; 92(2): 282 - 288. [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Judson Cardiac Sarcoidosis: There Is No Instant Replay Chest, July 1, 2005; 128(1): 3 - 6. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |
